GRML

Greenland Mines Ltd. Common Stock (GRML)

Stock · NASDAQ · Health Care

$6.02as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

Greenland Mines Announces New Mineral Finds and Capital Raises. Greenland Mines reported the addition of gallium and vanadium to its critical mineral portfolio as its 2026 Skaergaard PGM program concluded. The company also raised more than $17 million from existing shareholders and secured a securities purchase agreement for an additional $17.2 million, bringing total new capital above $59 million. It began trading on the Frankfurt Stock Exchange, expanding its market presence. These actions provide additional funding for its exploration and development projects.

Active signals

Support level
$0.3343
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

What GRML's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike31-8.9%42%
Bollinger Band Breakout17+0.4%65%
Bollinger Band Breakdown15-13.3%13%
Any 20-session window (baseline)-4.8%43%

Computed by MarketWall from daily closing prices since February 14, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About GRML

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gen…

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Employees
5

Fundamentals

1-day range
$5.82$7.09
Market cap
$22.19M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-9.81
Dividend yield
—
Beta
5.15
Avg. volume
8.75M
52-week range
$2.82$27.48

Greenland Mines Ltd. Common Stock Competitors

Chosen by industry and closest market cap.

  • GRML
    Greenland Mines Ltd. Common Stock
    $6
    ▼ 13.79%
    Market cap $22.19MP/E —
    $2.82$27.48
  • PLUR
    Pluri Inc. Common Stock
    $0.93
    ▼ 1.06%
    Market cap $19.53MP/E —
    $0.9$4.87
  • EVAX
    Evaxion A/S American Depositary Share
    $2.83
    ▲ 1.07%
    Market cap $24.98MP/E —
    $2.72$12.15
  • JSPR
    Jasper Therapeutics Inc. Common Stock
    $0.48
    ▼ 9.77%
    Market cap $18.10MP/E —
    $0.3151$2.69
  • CVM
    Cel-Sci Corporation Common Stock
    $1.79
    ▲ 2.87%
    Market cap $28.14MP/E —
    $0.89$10.24
  • QNCX
    Quince Therapeutics Inc. Common Stock
    $32.03
    ▼ 3.61%
    Market cap $30.04MP/E —
    $15.1$910
  • PASG
    Passage Bio Inc. Common Stock
    $3.5
    ▼ 2.78%
    Market cap $14.11MP/E —
    $3.29$20

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
1.79M
Disposed
178.5K

Institutional Ownership

March 31, 2026

Total shares held
9.35M
Total value held
$3.02M
Institutional holders
24
Top holders this quarter
  • Unknown5.37M
  • Unknown1.07M
  • Unknown740.5K
  • Unknown577.3K
  • Unknown370.0K
  • Unknown203.2K
  • Unknown200.0K
  • Unknown196.4K
  • Unknown143.5K
  • Unknown136.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.